Active Pharmaceutical Ingredients
Ketoprofen Sustained Release (SR) Pellets are designed to provide controlled and prolonged anti-inflammatory and analgesic effects. Using a polymer-based sustained-release coating, these pellets allow for gradual drug release over 12 to 24 hours, ensuring steady plasma concentrations, reduced dosing frequency, and improved patient compliance. Ideal for formulating extended-release capsules or sachets, these pellets can be tailored to meet various therapeutic and market-specific requirements.
| Component | Function |
|---|---|
| Ketoprofen | Active Pharmaceutical Ingredient (API) |
| Sugar Spheres / MCC Pellets | Inert core / Neutral starter spheres |
| HPMC / PVP | Binder / Layering polymer |
| Eudragit RS / Ethyl Cellulose | Sustained-release polymer coating |
| PEG 6000 / Triethyl Citrate | Plasticizer for flexible coating |
| Talc / Colloidal Silicon Dioxide | Anti-adherent / Glidant |
| Purified Water | Solvent (evaporated during processing) |
At Salius Pharma, we offer high-quality Ketoprofen SR Pellets through trusted USFDA-approved and WHO-GMP-certified manufacturing partners in India. Our pellets are tailored for performance, regulatory compliance, and manufacturing ease. We provide full support with regulatory documentation (CoA, MSDS, CTD format), custom drug load options, and logistics management for smooth distribution across Africa, Southeast Asia, CIS, and LATAM. With deep formulation and supply chain expertise, Salius Pharma is your reliable partner for sourcing premium pellet-based APIs.
We ensure prompt and reliable shipping worldwide. Delivery times may vary depending on destination, order volume, and regulatory requirements.
Looking to source Ketoprofen SR Pellets or other high-quality pharmaceutical pellet formulations?
Whether you need Active Pharmaceutical Ingredients (APIs), excipients, or regulatory support, our team is ready to provide reliable, compliant, and cost-effective solutions tailored to your market needs.
The contents of this page and any attachments are intended solely for the designated recipient(s) and may contain confidential and/or privileged information protected by law.
Any patented products are excluded from our offerings in regions where such patents are currently in force.
Sustained-release Ketoprofen ensures prolonged therapeutic effect, maintains steady plasma levels, and reduces dosing frequency—offering better patient compliance and fewer side effects.
Pellet-based systems enable controlled drug layering, customizable release profiles, and uniform drug dispersion—ideal for encapsulation and improving gastrointestinal tolerability.
Yes, we offer flexible drug loadings, coating variations, and pellet size customization to meet specific formulation, therapeutic, or market needs.
We supply pharmaceutical companies across Africa, Southeast Asia, CIS, and LATAM, providing end-to-end support including export logistics and regulatory documentation.